PROHANCE sol inj 25 mmol/50ml flacon

7680522732851 CH-52273 V08CA04 14.02.0.
PROHANCE sol inj 25 mmol/50ml flacon
PROHANCE sol inj 25 mmol/50ml flacon
1 / 2
google

Details

Product number
5227301
CPT
-
Packaging group
1 x 50 mL
Unit
Flasche(n)
Composition
gadoteridolum 279.3 mg corresp. 0.5 mmol, calteridolum calcicum, trometamolum, acidum hydrochloridum aut natrii hydroxidum corresp. natrium max 57.5 µg, aqua ad iniectabile ad solutionem pro 1 ml.

Articles (1)

ProHance 0.5 mmol/ml, soluzione iniettabile (flacone)
soluzione iniettabile (flacone)
1 x 50 mL
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
14/06/2025
Professional SmPC
Français
14/06/2025
Professional SmPC
Italien
14/06/2025

Detailed composition

Substance Quantity Type Category
(N/A)
279.3 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HBESI
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 236.05
Specialties list
Yes
Generic
No
SL addition date: 01/09/2020

Authorization holder

Bracco Suisse SA

6814 Cadempino

Authorization information

Swissmedic authorization number
52273
Drug name
ProHance 0.5 mmol/ml, soluzione iniettabile (flacone)
Galenic form
LSINJ
ATC Code
V08CA04
Authorization status
Z
Dispensation category
B
First authorization
29/08/1995
Authorization expiration date
31/12/9999
IT number
14.02.0.
Domain
Human medicine

Packaging details

Description (FR)
PROHANCE sol inj 25 mmol/50ml flacon
Description (DE)
PROHANCE Inj Lös 25 mmol/50ml Durchstfl
Market launch
29/08/1995
Narcotic (BTM)
No

Other packaging sizes

PROHANCE sol inj 5 fl 5 ml
5 x 5 mL FLAS
View